Jinyu Inventory vs Total Current Assets Analysis

600201 Stock

7.32 0.34 4.87%

Jinyu Bio financial indicator trend analysis is infinitely more than just investigating Jinyu Bio Technology recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jinyu Bio Technology is a good investment. Please check the relationship between Jinyu Bio Inventory and its Total Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Inventory vs Total Current Assets

Inventory vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jinyu Bio Technology Inventory account and Total Current Assets. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Jinyu Bio's Inventory and Total Current Assets is -0.25. Overlapping area represents the amount of variation of Inventory that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Jinyu Bio Technology Co, assuming nothing else is changed. The correlation between historical values of Jinyu Bio's Inventory and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Inventory of Jinyu Bio Technology Co are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Inventory i.e., Jinyu Bio's Inventory and Total Current Assets go up and down completely randomly.

Correlation Coefficient

-0.25

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Inventory

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most indicators from Jinyu Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jinyu Bio Technology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jinyu Bio Technology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

The current year's Tax Provision is expected to grow to about 62.3 M, whereas Selling General Administrative is forecasted to decline to about 230.1 M.

	2021	2022	2023	2024 (projected)
Operating Income	426.3M	297.7M	324.8M	316.5M
Total Revenue	1.8B	1.5B	1.6B	1.0B

Operating Income Total Revenue

Jinyu Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Total Current Assets	Non Current Assets Total	Non Currrent Assets Other	Short Term Investments	Non Current Liabilities Total
Total Assets		-0.16	0.59	1.0	0.87	0.98	0.86	0.65	0.95	0.31	0.97	-0.18	-0.38	0.78	0.96	0.98	0.92	-0.91	0.97	0.87	0.94	0.85	0.87	-0.76	0.13	0.8
Other Current Liab	-0.16		0.33	-0.18	-0.28	-0.16	-0.02	0.0	-0.25	0.01	-0.24	0.47	0.25	0.23	-0.3	-0.24	-0.27	0.05	-0.19	-0.34	-0.13	-0.09	-0.19	0.0	0.35	-0.15
Total Current Liabilities	0.59	0.33		0.54	0.37	0.5	0.46	0.55	0.49	-0.03	0.56	0.33	0.0	0.91	0.42	0.54	0.36	-0.61	0.57	0.34	0.6	0.67	0.37	-0.61	0.41	0.33
Total Stockholder Equity	1.0	-0.18	0.54		0.85	0.99	0.87	0.68	0.93	0.28	0.96	-0.24	-0.43	0.75	0.96	0.98	0.91	-0.89	0.97	0.85	0.94	0.86	0.86	-0.76	0.15	0.77
Other Liab	0.87	-0.28	0.37	0.85		0.86	0.69	0.33	0.93	0.55	0.85	-0.05	-0.18	0.65	0.94	0.87	0.93	-0.77	0.86	0.98	0.8	0.57	0.92	-0.49	-0.28	0.95
Retained Earnings	0.98	-0.16	0.5	0.99	0.86		0.91	0.64	0.93	0.3	0.95	-0.26	-0.45	0.73	0.96	0.98	0.93	-0.9	0.95	0.86	0.93	0.79	0.88	-0.73	0.11	0.81
Accounts Payable	0.86	-0.02	0.46	0.87	0.69	0.91		0.64	0.79	0.23	0.82	-0.33	-0.62	0.73	0.83	0.85	0.81	-0.86	0.88	0.7	0.91	0.68	0.84	-0.7	0.23	0.77
Cash	0.65	0.0	0.55	0.68	0.33	0.64	0.64		0.43	-0.29	0.55	-0.4	-0.58	0.61	0.49	0.56	0.35	-0.49	0.65	0.29	0.63	0.83	0.3	-0.51	0.37	0.29
Other Assets	0.95	-0.25	0.49	0.93	0.93	0.93	0.79	0.43		0.49	0.95	-0.13	-0.26	0.72	0.98	0.96	0.96	-0.92	0.93	0.96	0.92	0.7	0.93	-0.73	0.0	0.87
Long Term Debt	0.31	0.01	-0.03	0.28	0.55	0.3	0.23	-0.29	0.49		0.33	0.26	0.27	0.21	0.45	0.35	0.5	-0.37	0.34	0.58	0.34	-0.01	0.57	-0.17	-0.3	0.59
Net Receivables	0.97	-0.24	0.56	0.96	0.85	0.95	0.82	0.55	0.95	0.33		-0.23	-0.34	0.74	0.95	0.98	0.93	-0.91	0.94	0.88	0.92	0.8	0.88	-0.77	0.11	0.77
Inventory	-0.18	0.47	0.33	-0.24	-0.05	-0.26	-0.33	-0.4	-0.13	0.26	-0.23		0.75	0.19	-0.2	-0.18	-0.15	0.17	-0.21	-0.09	-0.21	-0.25	-0.11	0.19	-0.15	-0.07
Other Current Assets	-0.38	0.25	0.0	-0.43	-0.18	-0.45	-0.62	-0.58	-0.26	0.27	-0.34	0.75		-0.18	-0.37	-0.35	-0.25	0.42	-0.44	-0.19	-0.47	-0.49	-0.28	0.42	-0.36	-0.26
Total Liab	0.78	0.23	0.91	0.75	0.65	0.73	0.73	0.61	0.72	0.21	0.74	0.19	-0.18		0.68	0.74	0.63	-0.8	0.8	0.61	0.83	0.73	0.68	-0.66	0.26	0.67
Intangible Assets	0.96	-0.3	0.42	0.96	0.94	0.96	0.83	0.49	0.98	0.45	0.95	-0.2	-0.37	0.68		0.97	0.97	-0.89	0.96	0.96	0.92	0.74	0.94	-0.68	-0.04	0.88
Common Stock	0.98	-0.24	0.54	0.98	0.87	0.98	0.85	0.56	0.96	0.35	0.98	-0.18	-0.35	0.74	0.97		0.95	-0.91	0.95	0.89	0.93	0.79	0.89	-0.78	0.13	0.79
Property Plant Equipment	0.92	-0.27	0.36	0.91	0.93	0.93	0.81	0.35	0.96	0.5	0.93	-0.15	-0.25	0.63	0.97	0.95		-0.85	0.89	0.95	0.86	0.6	0.95	-0.65	-0.08	0.87
Treasury Stock	-0.91	0.05	-0.61	-0.89	-0.77	-0.9	-0.86	-0.49	-0.92	-0.37	-0.91	0.17	0.42	-0.8	-0.89	-0.91	-0.85		-0.91	-0.8	-0.95	-0.77	-0.86	0.89	-0.33	-0.77
Net Tangible Assets	0.97	-0.19	0.57	0.97	0.86	0.95	0.88	0.65	0.93	0.34	0.94	-0.21	-0.44	0.8	0.96	0.95	0.89	-0.91		0.87	0.98	0.84	0.9	-0.75	0.13	0.83
Deferred Long Term Liab	0.87	-0.34	0.34	0.85	0.98	0.86	0.7	0.29	0.96	0.58	0.88	-0.09	-0.19	0.61	0.96	0.89	0.95	-0.8	0.87		0.82	0.56	0.94	-0.54	-0.25	0.93
Long Term Investments	0.94	-0.13	0.6	0.94	0.8	0.93	0.91	0.63	0.92	0.34	0.92	-0.21	-0.47	0.83	0.92	0.93	0.86	-0.95	0.98	0.82		0.82	0.89	-0.82	0.25	0.8
Total Current Assets	0.85	-0.09	0.67	0.86	0.57	0.79	0.68	0.83	0.7	-0.01	0.8	-0.25	-0.49	0.73	0.74	0.79	0.6	-0.77	0.84	0.56	0.82		0.54	-0.8	0.44	0.46
Non Current Assets Total	0.87	-0.19	0.37	0.86	0.92	0.88	0.84	0.3	0.93	0.57	0.88	-0.11	-0.28	0.68	0.94	0.89	0.95	-0.86	0.9	0.94	0.89	0.54		-0.59	-0.12	0.95
Non Currrent Assets Other	-0.76	0.0	-0.61	-0.76	-0.49	-0.73	-0.7	-0.51	-0.73	-0.17	-0.77	0.19	0.42	-0.66	-0.68	-0.78	-0.65	0.89	-0.75	-0.54	-0.82	-0.8	-0.59		-0.67	-0.44
Short Term Investments	0.13	0.35	0.41	0.15	-0.28	0.11	0.23	0.37	0.0	-0.3	0.11	-0.15	-0.36	0.26	-0.04	0.13	-0.08	-0.33	0.13	-0.25	0.25	0.44	-0.12	-0.67		-0.26
Non Current Liabilities Total	0.8	-0.15	0.33	0.77	0.95	0.81	0.77	0.29	0.87	0.59	0.77	-0.07	-0.26	0.67	0.88	0.79	0.87	-0.77	0.83	0.93	0.8	0.46	0.95	-0.44	-0.26

Click cells to compare fundamentals

Jinyu Bio Account Relationship Matchups

Jinyu Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.6B	6.3B	6.6B	6.4B	6.9B	7.2B
Other Current Liab	156.5M	269.2M	238.7M	194.4M	63.6M	60.4M
Total Current Liabilities	548.0M	679.5M	689.2M	658.7M	840.4M	604.9M
Total Stockholder Equity	4.6B	5.0B	5.3B	5.1B	5.4B	5.6B
Other Liab	153.7M	335.8M	354.4M	380.6M	437.7M	459.6M
Retained Earnings	2.8B	3.1B	3.4B	3.5B	3.2B	3.3B
Accounts Payable	295.2M	330.3M	347.1M	354.4M	324.4M	176.8M
Cash	1.1B	1.5B	1.3B	1.4B	1.7B	884.3M
Other Assets	473.1M	447.9M	483.2M	513.8M	590.9M	620.5M
Net Receivables	643.0M	605.6M	729.1M	763.3M	857.5M	900.4M
Inventory	245.3M	350.7M	317.7M	333.5M	322.3M	388.8M
Other Current Assets	23.2M	16.1M	19.4M	19.8M	23.9M	35.7M
Total Liab	716.8M	1.0B	1.0B	1.0B	1.2B	720.8M
Intangible Assets	519.7M	576.7M	648.5M	668.5M	728.8M	765.3M
Property Plant Equipment	1.6B	1.7B	1.8B	1.8B	2.1B	2.2B
Net Tangible Assets	4.2B	4.5B	4.8B	4.7B	5.4B	4.4B
Deferred Long Term Liab	186.6M	238.7M	260.2M	322.5M	370.9M	389.5M
Total Current Assets	2.7B	3.2B	2.8B	2.7B	3.0B	3.3B
Non Current Assets Total	2.9B	3.1B	3.8B	3.7B	3.9B	3.1B
Non Currrent Assets Other	80.6M	160.8M	784.6M	711.5M	621.2M	511.3M
Short Term Investments	672.5M	639.5M	183.9M	46.9M	37.3M	35.4M
Non Current Liabilities Total	168.8M	335.8M	354.5M	380.9M	377.2M	275.3M
Other Stockholder Equity	133.8K	(196.7K)	(232.7K)	(410.1K)	(369.1K)	(350.6K)
Net Invested Capital	4.7B	5.0B	5.3B	5.1B	5.4B	5.5B
Net Working Capital	2.1B	2.5B	2.1B	2.0B	2.2B	1.9B
Good Will	130.8M	134.3M	94.5M	29.5M	11.4M	10.8M

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in Jinyu Stock

Balance Sheet is a snapshot of the financial position of Jinyu Bio Technology at a specified time, usually calculated after every quarter, six months, or one year. Jinyu Bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jinyu Bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jinyu currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Jinyu Inventory vs Total Current Assets Analysis

Inventory vs Total Current Assets

Inventory vs Total Current Assets Correlation Analysis

Correlation Coefficient

Inventory

Total Current Assets

Jinyu Bio fundamental ratios Correlations

Jinyu Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Jinyu Bio fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Jinyu Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity
Retained Earnings	+ 0.98	Total Assets
Common Stock	+ 0.98	Total Assets
Common Stock	+ 0.98	Total Stockholder Equity
Deferred Long Term Liab	+ 0.98	Other Liab

Long Term Investments	- 0.95	Treasury Stock
Treasury Stock	- 0.92	Other Assets
Net Tangible Assets	- 0.91	Treasury Stock
Treasury Stock	- 0.91	Common Stock
Treasury Stock	- 0.91	Net Receivables
Treasury Stock	- 0.91	Total Assets